跳至主要内容
临床试验/NCT03100474
NCT03100474进行中(未招募)不适用

Global Registry: ExAblate 4000 Transcranial MR Guided Focused Ultrasound (TcMRgFUS) of Neurological Disorders:

InSightec9 个研究点 分布在 4 个国家目标入组 500 人开始时间: 2016年12月最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
InSightec
入组人数
500
试验地点
9
主要终点
Clinical Rating Scale for Tremor

研究概览

简要总结

A global post approval study to collect safety and effectiveness data related to ExAblate Neuro for the treatment of certain disorders such as Essential Tremor, Parkinson's Movement Disorders, or Neuropathic Pain within the thalamus and/or pallidum.

详细描述

A global, multi-center, open-label, observational registry to capture safety and effectiveness data related to ExAblate Neuro, an MRI guided focused ultrasound device designed to lesion tissue deep within the brain using sound waves without the need for craniotomy. This registry includes certain regional and country specific approved thalamotomy and pallidotomy procedures using ExAblate Neuro for the treatment of various neurologic disorders such as essential tremor, Parkinson's movement disorders, and neuropathic pain. Treatment targets/indications are country/region dependent based on approved labeling within that region.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Meets labeling indication for use per information for prescribers
  • Target is accessible by Focused Ultrasound per treatment planning parameters

排除标准

  • Do not agree to participate or who are unlikely to participate over an extended period of time

结局指标

主要结局

Clinical Rating Scale for Tremor

时间窗: 5 year

CRST

次要结局

未报告次要终点

研究者

发起方
InSightec
申办方类型
Industry
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验